Sponsor:
Columbia University
Code:
NCT06084026
Conditions
Neuromuscular Diseases
Eligibility Criteria
Sex: All
Age: 1+
Healthy Volunteers: Accepted
Interventions
ActivPal
Brief summary:
Conditions
Neuromuscular Diseases
Study ID
NCT06084026
Start date
Nov 1, 2020
Status verified date
Jan, 2026
Completion date
Aug 31, 2026
Anticipated
Primary completion date
Aug 31, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 1+
Healthy Volunteers: Accepted
Enrollment
40 participants
Anticipated
Arms
Neuromuscular Disease
Control
Interventions
ActivPal
Primary outcome measure
Central contacts
Locations
Columbia University Irving Medical Center
Recruiting
New York, New York, United States, 10032
Contacts
Principal Investigator:
Michio Hirano, MD
Sponsor
Columbia University
Last update posted
Jan 23, 2026
Last verified
Jan, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Columbia University on 2026-01-23.